Search

Search Constraints

You searched for: Author/Creator Garralda, Elena

Search Results

1. 316 EVICTION Study: Preliminary results in solid tumor patients with ICT01, a first-in-class, gamma9 delta2 T cell activating antibody targeting butyrophilin-3A. (10th December 2020)

2. 387 A Phase II, multicenter study of the safety and efficacy of LAG525 in combination with spartalizumab in patients with advanced malignancies. (9th November 2020)

3. 408 Phase I, first-in-human trial evaluating BI 1387446 (stimulator of interferon genes [STING] agonist) alone and combined with BI 754091 (anti-programmed cell death [PD]-1) in solid tumors. (9th November 2020)

4. 412 First-in-human phase I/IIa trial to evaluate the safety and initial clinical activity of DuoBody®-PD-L1×4–1BB (GEN1046) in patients with advanced solid tumors. (10th December 2020)

5. 807 A multicenter open-label phase I/lb study of SO-C101 as monotherapy and in combination with pembrolizumab in patients with selected advanced/metastatic solid tumors. (9th November 2020)

8. Dynamic Angiogenic Switch as Predictor of Response to Chemotherapy-Bevacizumab in Patients With Metastatic Colorectal Cancer. (January 2019)

9. HER2/neu testing for anti-HER2-based therapies in patients with unresectable and/or metastatic gastric cancer. Issue 8 (8th May 2012)

10. Innovations and changes in the ICD‐11 classification of mental, behavioural and neurodevelopmental disorders. Issue 1 (2nd January 2019)